[18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond

Author:

Miceli Alberto,Jonghi-Lavarini Lorenzo,Santo GiuliaORCID,Cassarino Gianluca,Linguanti Flavia,Gazzilli Maria,Cimino Alessandra,Buschiazzo Ambra,Sorbello Stefania,Abenavoli Elisabetta,Conte Miriam,Pepponi Miriam,Di Dato Rossella,Rondini Maria,Salis Roberto,Tardelli Elisa,Nicolini Denise,Laudicella Riccardo,La Torre Flavia,Nappi Anna Giulia

Abstract

Abstract In the era of precision medicine, the optimization of oncological patient management with early and accurate tumor response assessment is crucial. In this scenario, [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) has gained an important role in providing prognostically relevant information. The first PET-based scoring system proposed in 1999 was the well-known European Organization for Research and Treatment of Cancer (EORTC) criteria. From that moment on and over the last 20 years, several PET/CT criteria have emerged and have been adapted to enhance the response assessment for specific tumor types and/or therapies, with only a few of them endorsed by guidelines. In this literature systematic review, we aimed to list and discuss the most relevant PET/CT criteria proposed for solid and non-solid [18F]FDG-avid tumors. A literature search extended until November 2022 on the PubMed/MEDLINE database was conducted. The criteria used to assess the response were first classified according to treatment type and specific cancer type. Then, the main findings of the criteria were analyzed and discussed. A widespread effort to standardize and identify the best [18F]FDG PET response criteria tailored for each oncological treatment emerged, also considering the introduction of new biological therapeutic agents and the increasingly essential post-treatment application of [18F]FDG PET/CT in different cancer diseases. To improve their impact on daily clinical practice, however, most of the proposed criteria need to be further validated.

Funder

Università degli studi "Magna Graecia" di Catanzaro

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3